CHLOROMYXIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chloromyxin, and what generic alternatives are available?
Chloromyxin is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in CHLOROMYXIN is chloramphenicol; polymyxin b sulfate. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLOROMYXIN?
- What are the global sales for CHLOROMYXIN?
- What is Average Wholesale Price for CHLOROMYXIN?
Summary for CHLOROMYXIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| DailyMed Link: | CHLOROMYXIN at DailyMed |
US Patents and Regulatory Information for CHLOROMYXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | CHLOROMYXIN | chloramphenicol; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 050203-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
